期刊文献+

Duchenne型肌营养不良症自然病程演变规律 被引量:5

Natural history of Duchenne muscular dystrophy
下载PDF
导出
摘要 Duchenne型肌营养不良症是最常见的X连锁隐性遗传性疾病,DMD基因突变导致抗肌萎缩蛋白缺失,不仅引起肌肉运动障碍,而且引起脊柱侧弯、认知功能障碍,以及泌尿系统疾病、呼吸系统疾病和心脏病等多系统疾病,患者最终于成年早期死于呼吸和循环衰竭。早期多学科综合治疗可以延缓疾病进程、提高患者生活质量,然而目前对该病的诊断与治疗存在明显延迟。本文拟从运动功能、认知功能、呼吸功能、心脏功能等方面综述Duchenne型肌营养不良症的自然病程,有助于临床医护人员对该病早期识别、早期诊断、早期治疗,使患者得到最大获益。 Duchenne muscular dystrophy(DMD) is X-linked recessive hereditary disease. DMD gene mutations result in dystrophin deficiency, which causes not only muscle movement disorders but alsoscoliosis, cognitive dysfunction, urinary tract diseases, respiratory diseases and heart diseases. Mostpatients die in early adult for respiratory and circulatory failure. Early multidisciplinary therapies willsignificantly delay disease progression and improve patients' quality of life. However, DMD diagnosis andtreatment exist significantly time delay now. In this study, we review the natural history of DMD, includingmotor, cognitive, respiratory and heart function, for improving DMD early recognition, diagnosis andtreatment, so as to benefit DMD patients.
作者 柯青 张利
出处 《中国现代神经疾病杂志》 CAS 2015年第5期355-359,共5页 Chinese Journal of Contemporary Neurology and Neurosurgery
基金 浙江省教育厅科研项目(项目编号:Y201223831) 浙江省卫生厅医药卫生科技计划项目(项目编号:2013KYA074) 浙江省科学技术厅钱江人才计划项目(项目编号:2013R10051)~~
关键词 肌营养不良 杜氏 肌营养不良蛋白 综述 Muscular dystrophy Duchenne Dystrophin Review
  • 相关文献

参考文献46

  • 1Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord, 1991,1:19-29.
  • 2Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier - Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar H, Weiss RB. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol, 2012, 71:304-313.
  • 3Dooley J, Gordon KE, Dodds L, MacSween J. Duchenne muscular dystrophy: a 30 · year population · based incidence study. Clin Pediatr (Phila), 2010, 49:177-179.
  • 4Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, Lochmiiller H, Bushby K. The burden of Duchenne muscular dystrophy: an international, cross - sectional study. Neurology, 2014,83:529-536.
  • 5Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K,McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol, 2010, 9:177-189.
  • 6Kim HK, Merrow AC, Shiraj S, Wong BL, Horn PS, Laor T. Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging andcorrelation with clinical assessments. Pediatr Radiol, 2013, 43: 1327-1335.
  • 7Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol, 2010, 9:77-93.
  • 8Imbornoni L, Price ET, Andrews J, Meaney FJ, Ciafaloni E, Cunniff C. Diagnostic and clinical characteristics of early -manifesting females with Duchenne or Becker muscular dystrophy. Am J Med Genet A, 2014,164A:2769-2774.
  • 9Hoffman EP, Arahata K, Minetti C, Bonilla E, Rowland LP. Dystrophinopathy in isolated cases of myopathy in females. Neurology, 1992, 42:967-975.
  • 10Bushby KM, Goodship JA, Nicholson LV, Johnson MA, Haggerty ID, Gardner-Medwin D. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord, 1993, 3: 57-64.

二级参考文献50

  • 1张成,陈维,肖露露,谭恩勋,罗绍凯,郑冬,叶欣,李中,卢锡林,刘颖.异基因脐带血干细胞移植治疗假肥大型肌营养不良症一例[J].中华医学杂志,2005,85(8):522-525. 被引量:7
  • 2张成,冯慧宇,黄绍良,方建培,肖露露,姚晓黎,陈纯,叶欣,曾缨,卢锡林,文剑明,张为西,李中,冯善伟,徐宏贵,黄科,周敦华,陈维,谢有梅,席静,张萌,黎阳,刘颖.脐血干细胞移植治疗假肥大型肌营养不良症[J].中华医学遗传学杂志,2005,22(4):399-405. 被引量:19
  • 3麻宏伟.Duchenne型肌营养不良症的诊断与治疗[J].中国实用儿科杂志,2007,22(7):552-554. 被引量:20
  • 4[1]Monaco AP,Bertelson CJ,Liechti-Gallati S,et al.An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.Genomics,1988,2:90-95.
  • 5[2]Wilton SD,Lloyd F,Carville K,et al.Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotide.Neuromuscul Disord,1999,9:330-338.
  • 6[3]van Deutekom JC,Bremmer-Bout M,Janson AA,et al.Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.Hum Mol Genet,2001,10:1547-1554.
  • 7[4]Aartsma-Rus A,Janson AA,Kaman WE,et al.Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.Hum Mol Genet,2003,12:907-914.
  • 8[5]Takeshima Y,Yagi M,Wada H,et al.Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.Pediatr Res,2006,59:690-694.
  • 9[6]Watchko J,O'Day T,Wang B,et al.Adeno-associated virus vectormediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice.Hum Gene Ther,2002,13:1451-1460.
  • 10[7]Kimura S,Ito K,Miyagi T,et al.A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.Brain Dev,2005,27:400-405.

共引文献23

同被引文献39

  • 1龚耀先,蔡太生.中国修订韦氏儿童智力量表[J].中国临床心理学杂志,1994,2(1):1-6. 被引量:129
  • 2袁云.骨骼肌疾病的临床病理诊断[J].中华神经科杂志,2006,39(8):505-507. 被引量:12
  • 3KIM HK, LAOR T, HORN PS, et al. T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments [l]. Radiology, 2010,255 (3) : 899-908.
  • 4V ALADI H, EKSTROM K, BOSSIOS A, et al. Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells [J]. Nat Cell BioI, 2007, 9 ( 6) : 654-659.
  • 5BRONZE-DA-ROCHA E. MicroRNAs expression profiles in cardiovascular diseases [J]. Biomed Res Int, 2014,2014: 985408.
  • 6MA G, WANG Y, LI Y, et al. MiR-206, a key modulator of skeletal muscle development and disease [J] . Int J BioI Sci, 2015,11(3):345-352.
  • 7HU J, KONG M, YE Y, et al. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy [J]. Neurochemistry, 2014, 129 (5): 877-883.
  • 8SOREIDE K. Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research [J]. J Clin Pat hol , 2009, 62( 1) : 1-5.
  • 9MUNTONI F, ZAHARIEV A IT, CALISSANO M, et al. Dystromirs as Serum Biomarkers for Monitoring the Disease Severity in Duchenne Muscular Dystrophy [J]. PLoS One, 2013, 8( 11) : e80263.
  • 10LI X, LI Y, ZHAO L, et al. Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients [J]. Mol Ther Nucleic Acids, 2014,3: e177.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部